CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 19631-19820 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T108","span":{"begin":0,"end":189},"obj":"Sentence"},{"id":"T63835","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Further investigation on structural modifications of the aromatic moiety of 62 revealed that compound 63 (Fig. 6 ) was the most promising anaplastic lymphoma kinase (ALK) inhibitor (IC 50 :"}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T17","span":{"begin":149,"end":157},"obj":"Disease"},{"id":"T26137","span":{"begin":149,"end":157},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005062"},{"id":"A67326","pred":"mondo_id","subj":"T26137","obj":"http://purl.obolibrary.org/obo/MONDO_0005062"}],"text":"Further investigation on structural modifications of the aromatic moiety of 62 revealed that compound 63 (Fig. 6 ) was the most promising anaplastic lymphoma kinase (ALK) inhibitor (IC 50 :"}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T108","span":{"begin":0,"end":189},"obj":"Sentence"}],"text":"Further investigation on structural modifications of the aromatic moiety of 62 revealed that compound 63 (Fig. 6 ) was the most promising anaplastic lymphoma kinase (ALK) inhibitor (IC 50 :"}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T16","span":{"begin":149,"end":157},"obj":"Phenotype"}],"attributes":[{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002665"}],"text":"Further investigation on structural modifications of the aromatic moiety of 62 revealed that compound 63 (Fig. 6 ) was the most promising anaplastic lymphoma kinase (ALK) inhibitor (IC 50 :"}